Medical Educational Programme in Soft Tissue Sarcoma

Disclosure of conflict of interest

Faculty members have been asked to disclose any potential conflict of interest in relation to their participation in the conference. Potential conflict of interest are considered any of the following:

Any financial interest in or arrangement with a company whose products or services are discussed in the lecture or that might be considered as part of the consensus process.

Any financial interest in or arrangement with a competing company.

Any other financial relationship, direct or indirect, or other situations that might raise the question of bias in the work presented or in the participation in the consensus process, including pertinent commercial or other sources of funding for the speaker or panellist or for the associated department or organisation, personal relationships or direct academic competition.


Jean-Yves Blay:
Novartis, PharmaMar, GSK, Roche: consultant or advisory board member, travel support and research support.

Nouri Bennini:
No significant relationships.

Angelo Dei Tos:
No significant relationships.

Alexander Fedenko:
Eli Lilly, Jansen, Roche: speakers bureau.

Rick Haas:
No significant relationships.

Akira Kawai:
GSK, MSD, Eisai, TAIHO: research support.

Zsuzsanna Papai:
No significant relationships.

Piotr Rutkowski:
GSK, Pfizer, Novartis, MSD: speakers bureau, consultant or advisory board member and travel support.

Daniel Vanel:
GSK, MSD, Eisai, TAIHO: research support.